ScholarIQanswers from OpenAlex

When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies

PaperCitations, authors & open-access status

When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies have?

ScholarIQcitation count

When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies has 57 citations in the OpenAlex counts ScholarIQ stores.

When was When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies published?

ScholarIQyear

When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies has 2018 year in the ScholarIQ index.

What is the open-access status of When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies?

ScholarIQoa status

When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies has bronze oa status in the ScholarIQ index.

What is the DOI of When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies?

ScholarIQdoi

The DOI for When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies is on the source record.

What is the PMID of When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies?

ScholarIQpmid

The PMID for When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies is on the source record.

What is the OpenAlex record for When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies?

ScholarIQopenalex

The OpenAlex for When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial